Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis
Study sponsor: Aclaris Therapeutics, Inc. · ACRS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-03-13Actual
Enrollment · participants14Actual
Source updated2026-03-12Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.